Pairing hyaluronic acid with a copper peptide is usually justified with something vague about hydration helping actives work. There is now a more specific reason, from a study that measured what the combination does to a particular collagen most skincare writing never mentions. The finding is genuinely interesting, and one number inside it is more instructive than the headline.
This article covers GHK-Cu as a cosmetic ingredient. It is not medical advice, and nothing here has been evaluated by the FDA.
Key Takeaways
- A 2023 study tested combinations of GHK-Cu and hyaluronic acid on human dermal fibroblasts and then on an ex-vivo skin model, measuring collagen I, IV, and VII [1].
- The combination promoted all three collagens, with a specific synergy on collagen IV [1].
- At a ratio of 1 part GHK-Cu to 9 parts low-molecular-weight hyaluronic acid, collagen IV rose 25.4-fold in the cell test and 2.03-fold in the ex-vivo skin test [1].
- The gap between those two numbers is the most useful part of the paper: the same combination looks dramatically different depending on how realistic the model is.
- Collagen IV sits at the dermal-epidermal junction rather than in the bulk dermis, so this is a different target from the collagen I story that usually accompanies peptides. The authors are affiliated with hyaluronic acid and peptide manufacturers.
What Collagen IV Is, and Why It Gets Studied Separately
When skincare talks about collagen it almost always means collagen I, the abundant structural protein that gives the dermis its bulk and firmness. Collagen IV is a different thing. It is a network-forming collagen concentrated in basement membrane, and in skin that means the dermal-epidermal junction, the interface where epidermis and dermis meet.
That junction is not flat in young skin. It is undulating, with interlocking projections that increase surface area between the layers and help anchor them together. With age it flattens. Interest in collagen IV comes from that: it is a structural target distinct from simply making more bulk collagen, and it relates to how well the two layers stay coupled.
What the Study Did
The researchers ran a two-stage design [1]. First, human dermal fibroblasts were treated with a series of GHK-Cu and hyaluronic acid combinations, with collagen I, IV, and VII expression measured by qRT-PCR. Then the best-performing formula from that screen was carried into an ex-vivo skin model, where collagen IV content was quantified by immunofluorescence.
That structure is worth crediting. Screening broadly in cell culture and then re-testing the winner in a more skin-like system is a more honest sequence than reporting cell-culture numbers alone, and it is what produced the paper’s most informative result.
The Finding, and the Number That Matters More
The combination promoted collagen I, IV, and VII, and the authors identified a synergy specifically on collagen IV, meaning the pair did more together than the components suggested individually. At the 1:9 ratio of GHK-Cu to low-molecular-weight hyaluronic acid, collagen IV synthesis rose 25.4-fold in the cell test.
In the ex-vivo skin test, the same combination produced a 2.03-fold increase.
Both numbers are real and both are from the same paper. The 25.4-fold figure is the one that would end up in marketing copy; the 2.03-fold figure is the one that came from tissue rather than isolated cells. Neither is the number for what happens on a living face, which was not tested here, but the direction of travel between them is the useful lesson. Effect sizes shrink as models get more realistic, and they shrink a lot. Any time you see a large fold-change quoted for a skincare ingredient, the first question is which model produced it.
Why the Ratio Finding Is Hard to Use
The most specific practical-sounding result, the 1:9 ratio with low-molecular-weight hyaluronic acid, is close to unusable as a shopping criterion.
Cosmetic ingredient lists are ordered by concentration, not quantified. A label showing both ingredients tells you nothing about the ratio between them. Hyaluronic acid molecular weight is rarely stated, and many products deliberately blend weights, which is a defensible formulation choice for other reasons but means you cannot identify a low-molecular-weight-dominant product from the label. And unless a brand has run this specific test on its own formula, matching a ratio from a paper would be coincidence rather than design.
This is a common shape for cosmetic ingredient research: a result precise enough to sound actionable, arriving in a market where the information needed to act on it is not disclosed.
How This Sits With the Rest of the GHK-Cu Evidence
GHK-Cu’s better-known activity is broad matrix and repair signalling, including effects across large numbers of genes related to remodelling and antioxidant defence [2]. A collagen IV result fits that picture rather than contradicting it, and it adds a target that is more specific than the usual claim.
The recurring caveat still applies. Topical delivery of GHK-Cu is genuinely difficult, and its own review literature describes formulation instability as a real and unresolved problem [3]. A study adding an ingredient in culture sidesteps the entire question of whether the complex arrives intact and in useful quantity through skin.
What to Actually Do With This
Layering hyaluronic acid with a copper peptide serum is sensible, cheap, and carries no real downside. This study gives that habit a more specific rationale than it previously had. What it does not give you is a reason to pay a premium for a product marketed on collagen IV or on a fold-change figure, because the figure being quoted almost certainly comes from the cell test rather than the skin test.
The realistic framing: a reasonable pairing with mechanistic support in models, no human outcome data, and one number in the paper quietly showing how much these effects deflate when the model gets closer to real tissue.
Frequently Asked Questions
Should I layer hyaluronic acid with GHK-Cu?
It is a reasonable and low-risk pairing, and there is now cell and ex-vivo work suggesting the two do more together than separately on collagen IV [1]. That is a better reason than most ingredient-pairing advice has, though it is not a human trial.
What ratio of GHK-Cu to hyaluronic acid should I look for?
The strongest effect in the study came at 1 part GHK-Cu to 9 parts low-molecular-weight hyaluronic acid [1]. In practice you cannot act on that, because cosmetic labels list ingredients in order rather than by ratio, and hyaluronic acid molecular weight is rarely disclosed at all.
Does hyaluronic acid molecular weight matter here?
In this study it did. The synergy was specifically reported with low-molecular-weight hyaluronic acid [1]. Most products do not tell you which they use, and many use a blend, so this is a finding you can understand but not reliably shop by.
Does this mean GHK-Cu works better with hyaluronic acid than alone?
On collagen IV, in these models, the combination outperformed the parts [1]. Extending that to visible results on skin is not supported. Collagen IV was measured in fibroblast culture and an ex-vivo skin model, neither of which reports what a face looks like after twelve weeks.
Why does collagen IV matter if collagen I is the famous one?
Collagen I is the bulk structural collagen of the dermis. Collagen IV is concentrated at the dermal-epidermal junction, the interface where the two layers meet. That junction flattens with age, which is one reason it is studied separately from bulk dermal collagen.
References
- Jiang F, Wu Y, Liu Z, Hong M, Huang Y. Synergy of GHK-Cu and Hyaluronic Acid on Collagen IV Upregulation via Fibroblast and Ex-Vivo Skin Tests. Journal of Cosmetic Dermatology (2023). PMID 37062921
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences (2018). PMID 29986520 (authors affiliated with Skin Biology, a company that sells copper-peptide products)
- Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically Applied GHK as an Anti-Wrinkle Peptide: Advantages, Problems and Prospective. BioImpacts (2025). PMID 39963574
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical or dermatological advice. As an Amazon Associate we earn from qualifying purchases.
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
